心衰-话题@MedSci

#心衰#

269篇内容 | 10125人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2138150, encodeId=92ea2138150f7, content=<a href='/topic/show?id=d90393941be' target=_blank style='color:#2F92EE;'>#达格列净#</a>改善不同射血分数<a href='/topic/show?id=072c5088466' target=_blank style='color:#2F92EE;'>#心力衰竭#</a>患者症状和身体活动，目前证据越来越充分了！<a href='/topic/show?id=56e0105612d5' target=_blank style='color:#2F92EE;'>#SGLT2i类药物#</a>会成为<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>的另一大类别的药物治疗！, objectTitle=Circulation-Heart Failure：达格列净改善不同射血分数心力衰竭患者症状和身体活动, objectType=article, longId=772939, objectId=5736e729396e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230520/1684556951917_1739456.jpg, objectUrl=/article/show_article.do?id=5736e729396e, replyNumber=1, likeNumber=157, createdTime=2023-05-21, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5736e729396e, moduleTitle=Circulation-Heart Failure：达格列净改善不同射血分数心力衰竭患者症状和身体活动, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5736e729396e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2149264, encodeId=1c562149264f6, content=<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>新四联, objectTitle=心衰, objectType=topic, longId=51926, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605779341502_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=52, createdTime=2023-07-22, rootId=0, userName=1dea4a7em68(暂无匿称), userId=90821711402, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2148775, encodeId=2be32148e7596, content=<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>终末期治疗太难了, objectTitle=心衰, objectType=topic, longId=51926, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605779341502_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=51, createdTime=2023-07-19, rootId=0, userName=1dea4a7em68(暂无匿称), userId=90821711402, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2147631, encodeId=3d7c214e63119, content=<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>新四联的分享, objectTitle=心衰, objectType=topic, longId=51926, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605779341502_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=51, createdTime=2023-07-12, rootId=0, userName=1dea4a7em68(暂无匿称), userId=90821711402, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2147274, encodeId=14e5214e274a9, content=<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>唯利西呱, objectTitle=心衰, objectType=topic, longId=51926, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605779341502_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=68, createdTime=2023-07-10, rootId=0, userName=1dea4a7em68(暂无匿称), userId=90821711402, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2146610, encodeId=1f57214661080, content=<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>诺欣妥，后起之秀, objectTitle=心衰, objectType=topic, longId=51926, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605779341502_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=49, createdTime=2023-07-06, rootId=0, userName=1dea4a7em68(暂无匿称), userId=90821711402, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2145777, encodeId=bc692145e7775, content=<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>SGLT-2抑制剂有多种作用, objectTitle=心衰, objectType=topic, longId=51926, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605779341502_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=52, createdTime=2023-07-01, rootId=0, userName=1dea4a7em68(暂无匿称), userId=90821711402, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2145419, encodeId=8dbf21454198a, content=<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>多学多思, objectTitle=心衰, objectType=topic, longId=51926, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605779341502_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=63, createdTime=2023-06-29, rootId=0, userName=1dea4a7em68(暂无匿称), userId=90821711402, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2144626, encodeId=0d2d214462629, content=<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>交流互动，学有所得, objectTitle=心衰, objectType=topic, longId=51926, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605779341502_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=56, createdTime=2023-06-25, rootId=0, userName=1dea4a7em68(暂无匿称), userId=90821711402, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2143808, encodeId=cf9021438081f, content=<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>心脏移植术寥寥无几, objectTitle=心衰, objectType=topic, longId=51926, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605779341502_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=37, createdTime=2023-06-20, rootId=0, userName=1dea4a7em68(暂无匿称), userId=90821711402, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2143601, encodeId=8436214360162, content=<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>药物治疗比较还是有局限性, objectTitle=心衰, objectType=topic, longId=51926, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605779341502_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=0, createdTime=2023-06-19, rootId=0, userName=1dea4a7em68(暂无匿称), userId=90821711402, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2143291, encodeId=1c962143291c4, content=<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>所有SGLT-2抑制剂应该都有类效应, objectTitle=心衰, objectType=topic, longId=51926, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605779341502_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=70, createdTime=2023-06-17, rootId=0, userName=1dea4a7em68(暂无匿称), userId=90821711402, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2143062, encodeId=50ff214306233, content=<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>中成药也是治疗心衰的一个可选项, objectTitle=心衰, objectType=topic, longId=51926, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605779341502_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=80, createdTime=2023-06-16, rootId=0, userName=1dea4a7em68(暂无匿称), userId=90821711402, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2142929, encodeId=596c214292958, content=<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>心衰新四联，值得推广, objectTitle=心衰, objectType=topic, longId=51926, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605779341502_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=47, createdTime=2023-06-15, rootId=0, userName=1dea4a7em68(暂无匿称), userId=90821711402, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2142317, encodeId=8972214231e2e, content=<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>唯立西呱，后起之秀, objectTitle=心衰, objectType=topic, longId=51926, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605779341502_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=77, createdTime=2023-06-12, rootId=0, userName=1dea4a7em68(暂无匿称), userId=90821711402, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2142019, encodeId=576621420197a, content=<a href='/topic/show?id=b696106319d3' target=_blank style='color:#2F92EE;'>#梅斯解读#</a>，有关<a href='/topic/show?id=142435598f' target=_blank style='color:#2F92EE;'>#BMI#</a>与<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>之间的关系，建议采用<a href='/topic/show?id=92cc4e923ec' target=_blank style='color:#2F92EE;'>#工具变量#</a>方法进行研究, objectTitle=Heart：心力衰竭患者体重指数与生存率的关系, objectType=article, longId=776089, objectId=cb2de760899b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230609/1686297660220_1739456.jpg, objectUrl=/article/show_article.do?id=cb2de760899b, replyNumber=0, likeNumber=113, createdTime=2023-06-10, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=cb2de760899b, moduleTitle=Heart：心力衰竭患者体重指数与生存率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb2de760899b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2142006, encodeId=7dd72142006e6, content=<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>新四联, objectTitle=心衰, objectType=topic, longId=51926, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201119/1605779341502_4754896.jpg, objectUrl=null, replyNumber=0, likeNumber=38, createdTime=2023-06-10, rootId=0, userName=1dea4a7em68(暂无匿称), userId=90821711402, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2126639, encodeId=32af212663928, content=<a href='/topic/show?id=977a1048622c' target=_blank style='color:#2F92EE;'>#Lecanemab#</a> 治疗<a href='/topic/show?id=3cbe9e7892e' target=_blank style='color:#2F92EE;'>#阿尔茨海默病#</a>，不用说是热点，不过<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a>药物<a href='/topic/show?id=4a9886e56ed' target=_blank style='color:#2F92EE;'>#艾塞那肽#</a>治疗<a href='/topic/show?id=a1f9485204d' target=_blank style='color:#2F92EE;'>#帕金森病#</a>; <a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>药物<a href='/topic/show?id=74b24141445' target=_blank style='color:#2F92EE;'>#地高辛#</a>可抑制<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>扩散，这确实令人惊奇！！, objectTitle=Nat Med：2023年11项值得关注的临床试验, objectType=article, longId=758254, objectId=ee06e5825492, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20230111/0c80815cf54e46d09ec9348e80ba2f63.jpg, objectUrl=/article/show_article.do?id=ee06e5825492, replyNumber=0, likeNumber=230, createdTime=2023-04-18, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=香港, moduleDTOList=[ModuleDTO(moduleId=ee06e5825492, moduleTitle=Nat Med：2023年11项值得关注的临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee06e5825492)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2126295, encodeId=8c38212629521, content=基于心周脂肪源<a href='/topic/show?id=e34f428e622' target=_blank style='color:#2F92EE;'>#外泌体#</a>miRNA-455-3p激活<a href='/topic/show?id=55452451c6' target=_blank style='color:#2F92EE;'>#AMPK#</a>介导的<a href='/topic/show?id=079fe7615f9' target=_blank style='color:#2F92EE;'>#线粒体自噬#</a>探讨<a href='/topic/show?id=9c2d1031961f' target=_blank style='color:#2F92EE;'>#黄芪#</a><a href='/topic/show?id=5eb12311579' target=_blank style='color:#2F92EE;'>#丹参#</a><a href='/topic/show?id=8f38105398c2' target=_blank style='color:#2F92EE;'>#药对#</a>改善<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a><a href='/topic/show?id=3a25105886b9' target=_blank style='color:#2F92EE;'>#能量代谢重构#</a>的机制。这类是<a href='/topic/show?id=57f74103502' target=_blank style='color:#2F92EE;'>#国自然#</a><a href='/topic/show?id=c030421865b' target=_blank style='color:#2F92EE;'>#基金#</a>申请的热点，将外泌体，<a href='/topic/show?id=5c1d22423c8' target=_blank style='color:#2F92EE;'>#中药#</a>药对，<a href='/topic/show?id=e93610588e44' target=_blank style='color:#2F92EE;'>#代谢重构#</a>扯到一起，不过可能并没有多少实际价值。事实上，心衰的能量重构确实意义比较大，黄芪也有重要作用，但是扯到外泌体，有点多余了。相反应该研究黄芪的有效成分，如<a href='/topic/show?id=b9091031981b' target=_blank style='color:#2F92EE;'>#黄芪甲苷#</a>是否有这样的作用，更有意义。, objectTitle=基于心周脂肪源外泌体miRNA-455-3p激活AMPK介导的线粒体自噬探讨黄芪丹参药对改善心衰能量代谢重构的机制, objectType=nsfc, longId=1046041, objectId=066d1046041fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/sci/nsfc_show.do?id=066d1046041fd, replyNumber=0, likeNumber=155, createdTime=2023-04-16, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=香港, moduleDTOList=[ModuleDTO(moduleId=066d1046041fd, moduleTitle=基于心周脂肪源外泌体miRNA-455-3p激活AMPK介导的线粒体自噬探讨黄芪丹参药对改善心衰能量代谢重构的机制, moduleType=nsfc, hrefUrl=https://www.medsci.cn/sci/nsfc_show.do?id=066d1046041fd)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=2126289, encodeId=a431212628960, content=<a href='/topic/show?id=9c2d1031961f' target=_blank style='color:#2F92EE;'>#黄芪#</a>-<a href='/topic/show?id=2aea10543844' target=_blank style='color:#2F92EE;'>#葶苈子#</a>药对调控<a href='/topic/show?id=c04310588229' target=_blank style='color:#2F92EE;'>#分子马达#</a><a href='/topic/show?id=923210588376' target=_blank style='color:#2F92EE;'>#MYO6#</a>影响<a href='/topic/show?id=eb5f86119b5' target=_blank style='color:#2F92EE;'>#自噬流#</a>进程干预<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>的作用机制研究, objectTitle=黄芪-葶苈子药对调控分子马达MYO6影响自噬流进程干预心衰的作用机制研究, objectType=nsfc, longId=1061587, objectId=c2a3106158e43, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/sci/nsfc_show.do?id=c2a3106158e43, replyNumber=0, likeNumber=103, createdTime=2023-04-16, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=香港, moduleDTOList=[ModuleDTO(moduleId=c2a3106158e43, moduleTitle=黄芪-葶苈子药对调控分子马达MYO6影响自噬流进程干预心衰的作用机制研究, moduleType=nsfc, hrefUrl=https://www.medsci.cn/sci/nsfc_show.do?id=c2a3106158e43)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

让心衰不再，让心脏回归正常

2020-05-29

侠胆医心 (审核中...)

前往app查看评论内容

#达格列净#改善不同射血分数#心力衰竭#患者症状和身体活动，目前证据越来越充分了！#SGLT2i类药物#会成为#心衰#的另一大类别的药物治疗！

Circulation-Heart Failure：达格列净改善不同射血分数心力衰竭患者症状和身体活动

2023-05-21发表于上海

1dea4a7em68(暂无匿称) (审核中...)

前往app查看评论内容

#心衰#新四联

2023-07-22

1dea4a7em68(暂无匿称) (审核中...)

前往app查看评论内容

#心衰#终末期治疗太难了

2023-07-19

1dea4a7em68(暂无匿称) (审核中...)

前往app查看评论内容

#心衰#新四联的分享

2023-07-12

1dea4a7em68(暂无匿称) (审核中...)

前往app查看评论内容

#心衰#唯利西呱

2023-07-10

1dea4a7em68(暂无匿称) (审核中...)

前往app查看评论内容

#心衰#诺欣妥，后起之秀

2023-07-06

1dea4a7em68(暂无匿称) (审核中...)

前往app查看评论内容

#心衰#SGLT-2抑制剂有多种作用

2023-07-01

1dea4a7em68(暂无匿称) (审核中...)

前往app查看评论内容

#心衰#多学多思

2023-06-29

1dea4a7em68(暂无匿称) (审核中...)

前往app查看评论内容

#心衰#交流互动，学有所得

2023-06-25

1dea4a7em68(暂无匿称) (审核中...)

前往app查看评论内容

#心衰#心脏移植术寥寥无几

2023-06-20

1dea4a7em68(暂无匿称) (审核中...)

前往app查看评论内容

#心衰#药物治疗比较还是有局限性

2023-06-19

1dea4a7em68(暂无匿称) (审核中...)

前往app查看评论内容

#心衰#所有SGLT-2抑制剂应该都有类效应

2023-06-17

1dea4a7em68(暂无匿称) (审核中...)

前往app查看评论内容

#心衰#中成药也是治疗心衰的一个可选项

2023-06-16

1dea4a7em68(暂无匿称) (审核中...)

前往app查看评论内容

#心衰#心衰新四联，值得推广

2023-06-15

1dea4a7em68(暂无匿称) (审核中...)

前往app查看评论内容

#心衰#唯立西呱，后起之秀

2023-06-12

侠胆医心 (审核中...)

前往app查看评论内容

#梅斯解读#，有关#BMI#与#心衰#之间的关系，建议采用#工具变量#方法进行研究

Heart：心力衰竭患者体重指数与生存率的关系

2023-06-10发表于上海

1dea4a7em68(暂无匿称) (审核中...)

前往app查看评论内容

#心衰#新四联

2023-06-10

侠胆医心 (审核中...)

前往app查看评论内容

#Lecanemab# 治疗#阿尔茨海默病#，不用说是热点，不过#糖尿病#药物#艾塞那肽#治疗#帕金森病#; #心衰#药物#地高辛#可抑制#乳腺癌#扩散，这确实令人惊奇！！

Nat Med：2023年11项值得关注的临床试验

2023-04-18发表于香港

侠胆医心 (审核中...)

前往app查看评论内容

全文收起基于心周脂肪源#外泌体#miRNA-455-3p激活#AMPK#介导的#线粒体自噬#探讨#黄芪##丹参##药对#改善#心衰##能量代谢重构#的机制。这类是#国自然##基金#申请的热点，将外泌体，#中药#药对，#代谢重构#扯到一起，不过可能并没有多少实际价值。事实上，心衰的能量重构确实意义比较大，黄芪也有重要作用，但是扯到外泌体，有点多余了。相反应该研究黄芪的有效成分，如#黄芪甲苷#是否有这样的作用，更有意义。

基于心周脂肪源外泌体miRNA-455-3p激活AMPK介导的线粒体自噬探讨黄芪丹参药对改善心衰能量代谢重构的机制

2023-04-16发表于香港

侠胆医心 (审核中...)

前往app查看评论内容

#黄芪#-#葶苈子#药对调控#分子马达##MYO6#影响#自噬流#进程干预#心衰#的作用机制研究

黄芪-葶苈子药对调控分子马达MYO6影响自噬流进程干预心衰的作用机制研究

2023-04-16发表于香港

科室
- - 订阅+
  - 更多科室
工具
服务